Selegiline, a Monoamine oxidase B (MAO-B) inhibitor with neuroprotective and antioxidant effects, is utilized for the oral therapy of Parkinson’s disease, Alzheimer’s disease, depression, narcolepsy and cocaine addiction [64]. Here, MAOB is linked to depressive symptom measurement.